🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST

Lycia Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Lycia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $54. The average 1-year stock price forecast is 63.29% higher than the current stock price, while the lowest is $43 (+30.03%) and the highest is $75 (+126.79%).

Price Target: $54 (+63.29%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$43$54$49$75
Change+30.03%+63.29%+48.17%+126.79%

Analyst Ratings

The average analyst rating for Lycia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '26
Strong Buy5
Buy0
Hold0
Sell0
Strong Sell0
Total5

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
LifeSci Capital
LifeSci Capital
Buy
Initiates
$48
BuyInitiates$48+45.15%Nov 17, 2026
Guggenheim
Guggenheim
Buy
Initiates
$75
BuyInitiates$75+126.79%Nov 17, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 17, 2026
Jefferies
Jefferies
Buy
Initiates
$50
BuyInitiates$50+51.19%Nov 17, 2026
Evercore ISI
Evercore ISI
Buy
Initiates
$43
BuyInitiates$43+30.03%Nov 17, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 6.74M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-2.21
EPS Next Year
-1.26
from -2.21
Fiscal YearFY 2024FY 2025FY 2026E
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
14.94M6.74M-
Revenue Growth
--54.87%-100.00%
Operating Income
-32.53M-39.88M-49.52M
Net Income
-26.50M-36.46M-43.86M
EPS
---2.21
Free Cash Flow
---42.90M
No. Analysts
--3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-2.21
Avg-2.21
Low-2.21

EPS Growth

EPS Growth20272028
High-
Avg-
Low-